
UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million …

The UK’s Medicines and Healthcare Products Agency (MHRA) has recommended that an Indian facility belonging to Pfizer’s Hospira unit be …

Indian cancer patients could be set to receive two of the world’s leading oncology drugs, MSD’s Keytruda and Bristol-Myers Squibb’s …

Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …

The US Food and Drug Administration and the World Health Organisation have raised serious concerns related to violations of good …

Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …

Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …

Drug firms in India are devising novel ‘benching’ models to manage employee turnover. Attrition rates for pharma companies in India …
Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …
GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …
Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …

The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …
Charity Médecins Sans Frontières is urging Indian prime minister Narendra Modi to stand tall and not give in to pressure …